A group of oncology-focused researchers led by co-principal investigator Ashesh B. Jani, MD, professor of radiation oncology at Winship Cancer Institute at Emory University, revealed that outcomes for patients with prostate cancer can improve by capitalizing on advanced PET imaging rather than merely depending solely on traditional imaging. Recent, study findings were published in the peer-reviewed The Lancet.
About 200,000 new cases of prostate cancer are diagnosed per year making it the most common solid cancerous tumor. While there are several therapies available for treatment, such as surgery and radiotherapy, significant technical-driven advances in both surgery and radiotherapy have improved both prostate cancer control outcomes as well as death rates.
However, regardless of such progress, about 30% of patients still treated with definitive local therapy experience recurrent disease—meaning the cancer comes back. The recurrence, meaning when the cancer again materializes after a prostatectomy, typically is indicated via rising PSA (blood test for prostate cancer). But the PSA level is, most of the time, limited in use in differentiating local recurrenc...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).